Study at a glance
Does vitamin D insufficiency describe the same health problem in everyone?
This review asks whether vitamin D insufficiency describes a distinct health problem between adequate supply and severe deficiency. It compares studies of hormone responses, calcium absorption and bone-related blood measurements in adults. Most studies used 25-hydroxyvitamin D, a blood measure of vitamin D supply.
How can the body respond when vitamin D supply falls?
The body can adjust hormone activity to help maintain calcium levels when vitamin D supply falls. Parathyroid hormone is one part of this response. However, studies did not identify one vitamin D level at which this adjustment starts or stops in everyone. A study of 488 older women and a review of 70 studies found no universal boundary.
What did studies of calcium absorption and bone-related blood measurements find?
In a one-year trial of 163 women after menopause, vitamin D supplements raised blood vitamin D levels substantially. The increase in calcium absorbed was small. A separate analysis of 11,855 adults found clearer changes in bone-related blood measurements below about 30 nmol/L. That finding does not prove higher levels are ideal for every health outcome.
Does a vitamin D insufficiency label prove disease?
Lower vitamin D supply can matter before severe deficiency develops, but the insufficiency label does not prove disease. The evidence does not show that everyone within one commonly used middle range has the same problem. The meaning depends on the person, the measurement and whether low levels persist. The review does not establish a universal personal target.
Read the full article below ↓Vitamin D insufficiency is best understood as a zone of reduced vitamin D supply in which physiology may begin to compensate before the unmistakable features of severe deficiency appear. It is therefore neither a guaranteed disease state nor simply a meaningless laboratory label. The useful question is what changes as 25-hydroxyvitamin D [25(OH)D] falls, how reliably those changes occur, and whether they justify a discrete boundary. This distinction develops the broader framework in Vitamin D Insufficiency Explained. For a shorter version of this evidence review, see Vitamin D Insufficiency as a Functional Intermediate State: Study Summary.
Insufficiency sits on a physiological continuum
Circulating 25(OH)D is primarily a marker of vitamin D supply. It is not the active hormone itself, and a fall in 25(OH)D does not translate one-for-one into a fall in biological action. Renal production of 1,25-dihydroxyvitamin D is tightly regulated by calcium, phosphate, parathyroid hormone (PTH) and other signals. When vitamin D supply falls, homeostatic responses can preserve serum calcium and active-hormone activity for a time. That is why Vitamin D Status vs Vitamin D Effect is an important distinction: a lower measured status can coexist with substantial physiological compensation.
The idea of an intermediate state arose from this physiology. Historically, “insufficiency” was used for milder vitamin D shortage associated with secondary hyperparathyroidism and increased bone turnover but without the hypocalcaemia, rickets or osteomalacia that characterise more severe depletion. That concept is biologically plausible because PTH can rise to maintain calcium economy as vitamin D substrate becomes less abundant. But a plausible mechanism does not prove that every person in a particular numerical band is functionally impaired.
This is also why the boundary between insufficiency and Vitamin D Deficiency Definitions cannot be treated as a switch. Severe deficiency is more consistently associated with impaired mineral handling, secondary hyperparathyroidism and, when prolonged, defective mineralisation. Above that severe range, compensatory physiology and individual variability become progressively more important.
What PTH tells us and what it does not
PTH has often been used as a functional marker because it tends to rise as 25(OH)D falls. If a single 25(OH)D concentration reliably produced maximal PTH suppression, it might provide a biological threshold. The evidence does not show such a universal point.
Sai and colleagues analysed 488 older women and reviewed 70 studies examining 25(OH)D and PTH. In their own cohort, PTH was inversely related to 25(OH)D, but there was no discrete suppression threshold across the observed range. Across the wider literature, reported PTH thresholds varied markedly. Their bone-turnover markers increased below about 18 ng/mL (45 nmol/L), supporting greater physiological concern at lower concentrations without establishing 30 ng/mL as a universal dividing line.
The practical lesson is that a gradual inverse relationship can be real even when a single threshold is not. A category such as insufficiency may describe increasing probability of compensatory stress, but it should not be confused with a diagnostic event. This distinction parallels the difference between Vitamin D Thresholds vs Targets: a threshold is an operational boundary, while physiology usually changes across a range.
Calcium absorption does not provide a clean 30 ng/mL boundary
Intestinal calcium absorption provided another proposed rationale for an intermediate state. Earlier work suggested that calcium absorption improved as 25(OH)D rose into the region around 30 ng/mL. More direct studies have not shown a consistent threshold at that level.
Hansen and colleagues studied postmenopausal women whose 25(OH)D values were in an “insufficient” range and measured fractional calcium absorption with dual stable calcium isotopes before and after vitamin D repletion. The study was designed specifically to test whether correction of insufficiency materially improved calcium absorption. Its results challenged the assumption that all people labelled insufficient have a functionally important calcium-absorption defect.
Gallagher and colleagues later randomised 163 postmenopausal women to placebo or graded vitamin D3 doses for one year while controlling calcium intake. Mean 25(OH)D rose substantially across doses, yet the absolute increase in absorbed calcium was small, and the investigators found no evidence of a reduced-absorption threshold between 10 and 66 ng/mL. Their conclusion was especially important for the intermediate-state concept: marked calcium malabsorption becomes more convincing at very low 25(OH)D, whereas the commonly discussed insufficiency range does not behave like a uniform physiological failure state.
These findings help explain why What Vitamin D Levels Represent should not be read as a direct meter of intestinal function. The blood concentration is informative, but the downstream response is regulated and outcome-specific.
Large clinical datasets place the clearest biochemical change lower
Shah and colleagues examined 11,855 adults and looked for breakpoints in calcium, phosphate, alkaline phosphatase and PTH. A biochemical breakpoint was identified below about 30 nmol/L (12 ng/mL), while the study did not find deleterious skeletal associations across the much broader 30 to 75 nmol/L range historically labelled “insufficient.” Most people below 30 nmol/L still did not show every abnormality, underscoring that even severe biochemical categories are probabilistic rather than deterministic.
This study does not prove that concentrations above 30 nmol/L are optimal for every outcome, nor does it prove that vitamin D has no effects in the intermediate range. It does show why the label “insufficiency” cannot be treated as though it identifies a single, validated bone disease. The strongest evidence for overt physiological disruption accumulates as concentrations move lower, while the middle range is dominated by gradients, compensatory responses and uncertainty.
A functional intermediate state is real as a concept, not as one universal band
The most defensible interpretation is therefore layered. First, vitamin D physiology can move through an intermediate phase in which homeostatic compensation becomes more active before severe deficiency produces overt disease. Second, the exact 25(OH)D value at which that compensation becomes important varies between people, outcomes and study methods. Third, the conventional laboratory category called “insufficiency” is an attempt to map that continuum into a practical band, not proof that the band itself is a natural biological compartment.
This explains why Vitamin D Sufficiency Explained should not be understood as the exact point at which compensation stops. Sufficiency is an operational description of adequacy, while the transition from lower supply to preserved function is gradual. It also explains why Population Reference Ranges Explained can orient interpretation without defining an individual physiological requirement.
An intermediate state can therefore be physiologically meaningful without being universally diagnosable from one number. The meaning lies in the direction of change (lower substrate availability, increasing reliance on compensation and rising probability of adverse mineral consequences) rather than in a sharp boundary that every person crosses at the same concentration.
Measurement and individual context still matter
Even a well-chosen threshold is applied to a measurement that has biological and analytical variability. Season, recent exposure, body composition, illness, binding proteins and assay characteristics can influence 25(OH)D. The implications are developed in Why Vitamin D Results Differ and Limitations of Vitamin D Blood Tests. A person measured just below a category boundary is not necessarily physiologically different from the same person measured just above it.
For that reason, the term “insufficiency” is most useful when it prompts contextual interpretation rather than automatic conclusions. It can flag reduced vitamin D supply and possible physiological strain, but its significance depends on how low the value is, whether it is persistent, the clinical setting, calcium and phosphate physiology, and the purpose for which the threshold was defined.
What the evidence supports
The evidence supports a continuum from adequate vitamin D supply through progressively constrained supply to severe deficiency. It supports compensatory endocrine responses, especially PTH-mediated maintenance of calcium balance, and it supports clearer biochemical and skeletal concern at lower concentrations. It does not support the claim that every person between 20 and 30 ng/mL has a distinct physiological disorder, or that 30 ng/mL is a universal point separating dysfunction from normality.
That conclusion does not make insufficiency meaningless. It makes the term more precise. Used carefully, it describes a potentially vulnerable intermediate region whose physiological significance must be interpreted rather than presumed. Used as a rigid diagnosis, it overstates what the evidence can establish. The neighbouring concepts in Vitamin D Thresholds vs Targets and Population Reference Ranges Explained are therefore part of the interpretation, not optional background.
Scientific sources and publication details
Karen E Hansen et al. Vitamin D Insufficiency: Disease or No Disease?. Journal of Bone and Mineral Research. 2008;23(7):1052 to 1060. PMID 18302509; PMCID PMC2574556; DOI 10.1359/JBMR.080230.
A J Sai et al. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. Journal of Clinical Endocrinology & Metabolism. 2011;96(3):E436: E446. PMID 21159838; PMCID PMC3047227; DOI 10.1210/jc.2010-1886.
J Christopher Gallagher et al. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550 to 3556. PMID 22855333; PMCID PMC3462946; DOI 10.1210/jc.2012-2020.
Sonali Shah et al. Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease. Journal of Clinical Endocrinology & Metabolism. 2017;102(7):2321 to 2328. PMID 28379394; DOI 10.1210/jc.2016-3189.
A Catharine Ross et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53 to 58. PMID 21118827; PMCID PMC3046611; DOI 10.1210/jc.2010-2704.
Related reading
Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bone health of the elderly is a major global health concern, since about 1 in 3 women and 1 in 5 men suffer from bone loss and fractures, often called osteoporosis, in old age.
Original paper ↗Read more →Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
The present study is aimed to explore whether the aqueous extract of Mori Folium (MF) exhibits bone protective effect by regulating calcium and redox homeostasis in diabetic rats, and to identify the signaling pathways involved in this process.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study
Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.
Original paper ↗Read more →Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial
This secondary analysis of the DASH trial aimed to determine the effect of dietary patterns on blood concentrations of calcitriol, parathyroid hormone (PTH), ionized calcium, and urinary excretion of calcium and phosphorus.
Original paper ↗Read more →Evaluation of vitamin D status, parathyroid hormone, and calcium among Iranian pregnant women with preeclampsia: A case-control study
The aim of the present study was to evaluate the association between vitamin D status and preeclampsia.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer
The aim of this study was to examine pre-diagnostic levels of vitamin D (25OHD), PTH and calcium in relation to survival after breast cancer.
Original paper ↗Read more →The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
Background and objectives: Vitamin D is an essential vitamin that plays a key role in maintaining physiological calcium balance, and is also a pivotal element in the formation of bone structure.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
This study examined changes in plasma and effluent levels of total calcium, phosphate, PTH, and FGF-23 in individuals undergoing TPE.
Original paper ↗Read more →Associations between serum calcium, 25(OH)D level and bone mineral density in older adults
Calcium and vitamin D play important roles in bone health as essential nutrients.
Original paper ↗Read more →Vitamin D and Vitamin K in Calcium Handling, Bone and Vascular Physiology: Evidence Synthesis
Evidence synthesis integrating vitamin D, vitamin K-dependent proteins, calcium handling, bone outcomes and vascular calcification evidence.
Read more →Three-year follow-up of serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in nursing home residents who had received 12 months of daily bread fortification with 125 μg of vitamin D3
We conducted a single-arm clinical trial in institutionalized seniors, on the effects of high-dose vitamin D3-fortified bread daily intake (clinicaltrials.gov registration NCT00789503).
Original paper ↗Read more →Vitamin D Insufficiency as a Functional Intermediate State: Study Summary
A concise evidence summary of vitamin D insufficiency as an intermediate state of reduced supply, including compensatory physiology and functional interpretation.
Read more →Original sources
Vitamin D Insufficiency: Disease or No Disease?
Published in Journal of Bone and Mineral Research (2008).
Publication details
Karen E Hansen et al. Vitamin D Insufficiency: Disease or No Disease?. Journal of Bone and Mineral Research. 2008;23(7):1052 to 1060. PMID 18302509; PMCID PMC2574556; DOI 10.1359/JBMR.080230.
Relationship between Vitamin D, Parathyroid Hormone, and Bone Health
Published in Journal of Clinical Endocrinology & Metabolism (2011).
Publication details
A J Sai et al. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. Journal of Clinical Endocrinology & Metabolism. 2011;96(3):E436: E446. PMID 21159838; PMCID PMC3047227; DOI 10.1210/jc.2010-1886.
The Effect of Vitamin D on Calcium Absorption in Older Women
Published in Journal of Clinical Endocrinology & Metabolism (2012).
Publication details
J Christopher Gallagher et al. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550 to 3556. PMID 22855333; PMCID PMC3462946; DOI 10.1210/jc.2012-2020.
Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease
Published in Journal of Clinical Endocrinology & Metabolism (2017).
Publication details
Sonali Shah et al. Serum 25-Hydroxyvitamin D Insufficiency in Search of a Bone Disease. Journal of Clinical Endocrinology & Metabolism. 2017;102(7):2321 to 2328. PMID 28379394; DOI 10.1210/jc.2016-3189.
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
Published in Journal of Clinical Endocrinology & Metabolism (2011).
Publication details
A Catharine Ross et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53 to 58. PMID 21118827; PMCID PMC3046611; DOI 10.1210/jc.2010-2704.